4-Methylamphetamine

From Self-sufficiency
Jump to: navigation, search
4-Methylamphetamine
File:4-Methylamphetamine.svg
Systematic (IUPAC) name
1-(4-methylphenyl)propan-2-amine
Identifiers
CAS Number 22683-78-9
ATC code none
PubChem CID 199116
ChemSpider 172349
Chemical data
Formula C10H15N
Molar mass 149.23 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

4-Methylamphetamine (4-MA; PAL-313; Aptrol) is a stimulant and anorectic drug of the phenethylamine and amphetamine chemical classes. It acts as a potent and balanced serotonin, norepinephrine, and dopamine releasing agent with Ki affinity values of 53.4 nM, 22.2 nM, and 44.1 nM at the serotonin, norepinephrine, and dopamine transporters, respectively.[1][2] 4-MA was investigated as an appetite suppressant in 1952 and was even given a trade name, but development was apparently never completed.[2]

In animal studies, 4-MA was shown to have the lowest rate of self-administration out of a range of similar drugs tested (the others being 3-methylamphetamine, 4-fluoroamphetamine, and 3-fluoroamphetamine), likely as a result of having the highest potency for releasing serotonin relative to dopamine.[3]

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL (2005). "Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs". J Pharmacol Exp Ther. 313 (2): 848–54. doi:10.1124/jpet.104.080101. PMID 15677348. 
  2. 2.0 2.1 GELVIN EP, McGAVACK TH (1952). "2-Amino-1-(p-methylphenyl)-propane (aptrol) as an anorexigenic agent in weight reduction". N Y State J Med. 52 (2): 223–6. PMID 14890975. 
  3. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL. Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. Journal of Pharmacology and Experimental Therapeutics. 2005 May;313(2):848-54. PMID 15677348